Blog Layout

New haematologist joining the Ballarat Cancer Care team
August 27, 2024

We are excited to announce Dr Tishya Indran will be joining our team as of 18th September 2024.



Dr Tishya Indran is a haematologist with an interest in platelet and blood disorders. She graduated from The University of Adelaide and completed dual training in clinical and laboratory haematology in 2018. She trained at The Royal Adelaide Hospital, The Queen Elizabeth Hospital, SA, Liverpool Hospital, NSW, Monash VIC, Peter MacCallum Cancer Centre and The Alfred Hospital, VIC. She has experience in treating benign and malignant haematological disorders.


Dr Tishya Indran has also undertaken a laboratory haemostasis fellowship in Loyola University Medical Centre, Chicago. At present, she is completing her PhD through the Walter and Eliza Hall Institute with a focus in haemostasis and thrombosis. She also has a clinical and laboratory attachment with the Royal Melbourne Hospital haematology laboratory while undertaking her PhD. 



During her free time, she enjoys playing tennis and spending time with her family.


December 3, 2024
We are pleased to announce palliative care physician Dr Russell Pearce will be joining our team in February 2025.
4th Dose COVID-19 Vaccine for Immunocompromised Patients
March 1, 2022
The Australian Technical Advisory Group on Immunisation (ATAGI) has approved a fourth dose of a COVID-19 vaccine for people with weakened immune systems. People aged 18 years or older with weakened immune system who received a 3-dose primary course of the COVID-19 vaccine are now recommended to receive the fourth dose ≥ 3 months after their third dose. This is expected to improve protection against symptomatic infection, serious illness, or death from COVID-19 infection.
COVID-19 Vaccine Booster Shots In Our Patients With Cancer
November 8, 2021
The Government and the Medical advisory group (ATAGI) have release new recommendations last week for individuals who are severely immunocompromised in regards to the COVID-19 vaccine. These recommendations will affect some (but not all) of our patients. As always, we are happy to discuss any of the recommendations further with all of our patients.
COVID-19 Vaccination FAQs July 2021
July 20, 2021
In the last few months, I have been inundated with many questions regarding COVID-19 vaccination and blood clots from patients and other health practitioners. In this article, I have compiled these frequently asked questions.
New PBS listings!
July 2, 2021
Despite a global pandemic, new data relating to oncology treatments continues to be published, and it seems that this is increasingly translating into improved drug access here in Australia.
Astra Zeneca (AZ) vaccine safety information
March 26, 2021
In light of recent reports of clotting events following Astra Zeneca (AZ) vaccine in Europe - we have been frequently asked questions regarding the safety of AZ vaccine in patients with previous clot events and/or blood problems
February 25, 2021
Two vaccines against the coronavirus have now been approved for use in Australia, role-out of the vaccine begins this week in high-risk populations.
January 18, 2021
Dr Swe Myo Htet Consultant Haematologist MBBS, FRACP, FRCPA, MRCP
Blood clot disorder and long distance car-travel
December 2, 2020
Blood specialist, Dr. Pohan Lukito, answers frequently asked question regarding blood clot disorder and long distance car-travel
Exercise and Cancer
October 26, 2020
Patients with a malignancy, and in particular those receiving treatment for a malignancy, often experience fatigue. And while adequate rest is important, there has been increasing evidence over the past few years that a regular exercise programme can have a considerable benefit on this fatigue, as well and many other treatment related side effects.
More Posts
Share by: